孕妇补硒对母亲、胎儿及新生儿结局影响的系统评价与荟萃分析
该系统评价与荟萃分析检索了多个数据库,纳入随机对照试验和非随机干预研究,比较孕妇补硒与安慰剂或不治疗的效果。结果显示,补硒对<37周早产(RR 0.65,95%CI 0.26-1.63)和<34周早产(RR 1.05,95%CI 0.59-1.44)的影响均无法确定,证据确定性极低。作者认为证据有限,需进一步开展更大样本、更具代表性人群的试验。
要点
- 补硒对<37周早产的影响无法确定(RR 0.65,95%CI 0.26-1.63;证据确定性极低)。
- 补硒对<34周早产的影响无法确定(RR 1.05,95%CI 0.59-1.44;证据确定性极低)。
- 作者认为需进一步开展更大样本、更具代表性人群的试验。
核心结论
- 关于孕期补硒效果的证据有限。
- 需要进一步开展更大样本、更具代表性人群、并在试验入组时可靠评估母亲硒状态的试验。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE、Embase、CINAHL、Global Index Medicus和Cochrane Library,检索日期为2022年6月23日,无语言或时间限制。
- 纳入标准为比较孕妇补硒与安慰剂或不治疗的随机对照试验和非随机干预研究。
- 最终纳入8项试验(1851名妇女)和1项前瞻性队列研究(71,728名妇女)报告了至少1项结局。
- 采用随机效应模型进行荟萃分析,使用RoB 2和ROBINS-I工具评估研究质量,采用GRADE评估证据确定性。
主要发现
- 补硒对<37周早产的影响无法确定(RR 0.65,95%CI 0.26-1.63;证据确定性极低)。
- 补硒对<34周早产的影响无法确定(RR 1.05,95%CI 0.59-1.44;证据确定性极低)。
局限性
- 研究数量少且人群间临床异质性高。
- 证据确定性极低。
- 作者指出需要进一步开展更大样本、更具代表性人群的试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Low maternal selenium status has been associated with poor pregnancy outcomes, including preterm birth. This study aimed to evaluate available evidence of the effects of selenium supplementation during pregnancy on preterm birth and related maternal, fetal, and newborn outcomes. DATA SOURCES: MEDLINE, Embase, CINAHL, Global Index Medicus, and the Cochrane Library were systematically searched on June 23, 2022, without language or time restrictions. STUDY ELIGIBILITY CRITERIA: Randomized controlled trials and nonrandomized interventional studies were included if they compared the effects of selenium supplementation with placebo or no treatment among pregnant women. The review protocol was registered in the International Prospective Register of Systematic Reviews (identification number: CRD42022383669). METHODS: For outcomes reported by ≥1 study, a meta-analysis was conducted. Because of the small number of studies and high clinical heterogeneity between populations, random-effects models were used. The Risk of Bias 2 and Risk Of Bias In Non-randomized Studies - of Interventions tools were used to assess study quality, and Grading of Recommendations Assessment, Development, and Evaluation analysis was used to determine the certainty of evidence for each outcome. RESULTS: Literature searches identified 5105 unique records, and 32 studies met the eligibility criteria. Of note, 11 reports were not included for analysis following research integrity assessments. Moreover, 10 trials and 3 observational studies met the inclusion criteria; however, only 8 trials (1851 women) and 1 prospective cohort study (71,728 women) reported on at least 1 review outcome. Our results could not determine the effect of selenium supplementation on preterm birth at <37 weeks of gestation (relative risk, 0.65; 95% confidence interval, 0.26-1.63; very low certainty evidence) and <34 weeks of gestation (relative risk, 1.05; 95% confidence interval, 0.59-1.44; very low certainty evidence). CONCLUSION: There is limited evidence on the effects of selenium supplementation during pregnancy. Further trials, with larger sample sizes, more representative populations, and reliable assessment of maternal selenium status at trial entry, are required.
引用
- McDougall AR, Dore G, Aboud L, et al. The effect of selenium supplementation in pregnant women on maternal, fetal, and newborn outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023. PMID: 37716440. doi:10.1016/j.ajogmf.2023.101160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。